Methods for detecting nucleic acid molecules encoding flh2882, a GPCR showing homology to the 5HT family of receptors
AssigneeMillennium Pharmaceuticals, Inc.
InventorsM. Alexandra Glucksmann, Keith Robison
Life of this patent
Estimating the term…
Loading patent…
AssigneeMillennium Pharmaceuticals, Inc.
InventorsM. Alexandra Glucksmann, Keith Robison
Estimating the term…
The present invention is based on the identification of a novel G-protein coupled receptor (GPCR) that is expressed predominantly in the brain and nucleic acid molecules that encoded the GPCR, referred to herein as the flh2882 protein and flh2882 gene respectively. Based on this identification, the present invention provides: 1) isolated flh2882 protein; 2) isolated nucleic acid molecules that encode an flh2882 protein; 3) antibodies that selectively bind to the flh2882 protein; 4) methods of isolating allelic variants of the flh2882 protein and gene; 5) methods of identifying cells and tissues that express the flh2882 protein/gene; 6) methods of identifying agents and cellular compounds that bind to the flh2882 protein; 7) methods of identifying agents that modulate the expression of the flh2882 gene; and 8) methods of modulating the activity of the flh2882 protein in a cell or organism.
An isolated nucleic acid molecule selected from the group consisting of:
An isolated protein selected from the group consisting of:
A method for detecting the presence of a protein selected from the group consisting of:
A method for detecting the presence of a nucleic acid molecule selected from the group consisting of:
A method for identifying a compound which binds to a protein selected from the group consisting of:
A method for modulating the activity of a protein selected from the group consisting of:
Dependencies are inferred from the claim text.